Spinal cord injuries are rising in America, but technology is coming to the rescue. Here's how.
Israeli-Canadian NurExone Biologic is developing groundbreaking exosome technology for treatment of spinal cord injuries and additional indications
Stay updated with breaking news from Daniel Offen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Israeli-Canadian NurExone Biologic is developing groundbreaking exosome technology for treatment of spinal cord injuries and additional indications
Calgary, Alberta--(Newsfile Corp. - June 15, 2022) - NurExone Biologic Inc. (formerly, EnerSpar Corp.) (TSXV: NRX) (the "Company") is pleased to announce that it has completed its previously announced
Innocan Pharma operates three primary and distinct segments: research and development (R&D) of CBD-loaded exosomes, R&D of the use of CBD-loaded liposomes, and commercialization and sale of branded CBD-integrated pharmaceutical and topical treatment products
Bird flu outbreak in Israel, Lebanon results in culling over 500,000 birds; 5,000 wild cranes found dead at the Hula Lake nature reserve.
Scientists say their work may cause a pivot in research, as it suggests THC is the more promising cannabinoid than CBD